Oncology

AstraZeneca has more than half a century of experience in cancer research and the development of effective cancer therapies. Our ambition is to give even more cancer patients hope for better treatment with the help of new active ingredients. That's why we focus on research and development to create a new generation of medicines that have the potential to redefine cancer treatment.

In Switzerland, we are currently conducting 14 international or national oncology trials in ovarian, breast-, bladder- and non-small cell lung cancer (as of 02/2020).

We’re concentrating on these scientific platforms that we believe show the greatest potential for yielding effective cancer medicines.

^{CH-2305; 03/2020}